Akums Drugs and Pharmaceuticals Limited has intimated the stock exchanges about its scheduled participation in institutional investor meets. The disclosure is made pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Meeting Schedule Details
- First Meeting: Institutional Investor Meeting on September 28, 2026, starting at 09:00 AM IST onwards
- Second Meeting: Institutional Investor Meeting on September 29, 2026, starting at 09:00 AM IST onwards
- Meeting Type: Multiple One on One & Group Meetings
- Location/Mode: Mumbai/Physical mode for both meetings
Key Disclosures
The company explicitly states that no unpublished price sensitive information pertaining to the company will be shared during these meetings with investors.
Contingency Note
The disclosure notes that the schedule may be subject to change due to exigencies on the part of investors or the company.
Additional Information
A copy of this disclosure has been updated on the company's website at www.akums.in.